Mutations in the PI3K/AKT/mTOR pathway, including PIK3CA, AKT1 and PTEN are infrequent in thyroid cancer, though they can act as early driver mutations in certain RAS-like subtypes. Here, AKT1 is linked to thyroid gland carcinoma.